Predicta Biosciences
Predicta Biosciences raises $23.4M Series A
Quick Facts
Predicta Biosciences: Series A Funding Round
Predicta Biosciences has successfully raised $23.4M in Series A funding.
Company Overview
Precision medicine platform for predictive biomarker discovery
Funding Details
The Series A round was led by Engine Ventures.
Company Information
- Headquarters: Cambridge, MA
- Founded: 2020
- Employees: 40+
- Category: HealthTech
Investment
Predicta Biosciences plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Engine Ventures: Verified investor in Series A
Key Investors
About the Author
Related Company Reports
Abridge Raises $150M Series C to Transform HealthTech
Abridge has secured $150M Series C in funding to accelerate growth and innovation in the healthtech sector. Medical AI scribe platform automatically documenting patient-provider conversations and generating clinical notes...
Innovaccer Raises $275M Series F to Transform HealthTech
Innovaccer has secured $275M Series F in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform unifying patient data and providing analytics for value-based care and population health manage...
Truveta Raises $95M Series B to Transform HealthTech
Truveta has secured $95M Series B in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform aggregating de-identified patient records to accelerate medical research and drug development...
